Corcept Therapeutics Inc (0I3Q)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 0I3Q market cap is 1.88B. The company's latest EPS is USD 1.0297 and P/E is 54.70.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 306.49M | 353.87M | 365.98M | 401.86M | 482.38M |
| Operating Income | 111.61M | 128.2M | 124.48M | 98.63M | 107.28M |
| Net Income | 94.18M | 106.01M | 112.51M | 101.42M | 106.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 412.31M | 571.73M | 423.76M | 583.43M | 621.52M |
| Total Liabilities | 41.13M | 48.39M | 47.95M | 81.59M | 114.81M |
| Total Equity | 371.18M | 523.34M | 375.81M | 501.84M | 506.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 136.12M | 151.97M | 167.89M | 120.32M | 127.04M |
| Investing | -117.83M | -119.26M | 136.13M | -114.33M | 90.91M |
| Financing | -28.65M | 12.21M | -302.59M | -17.28M | -148.72M |
| Market Cap | 1.88B |
| Price to Earnings Ratio | 54.70 |
| Price to Sales Ratio | 12.04 |
| Price to Cash Ratio | 42.83 |
| Price to Book Ratio | 11.46 |
| Dividend Yield | - |
| Shares Outstanding | 103.08M |
| Average Volume (1 week) | 1.47k |
| Average Volume (1 Month) | 975 |
| 52 Week Change | 0.00% |
| 52 Week High | 18.23 |
| 52 Week Low | 18.23 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Corcept Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.corcept.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
